# Convalescent Plasma Therapy for COVID-19 Patients

> **NCT04565197** · EARLY_PHASE1 · UNKNOWN · sponsor: **Lahore General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- SARS-CoV Infection

## Interventions

- **BIOLOGICAL:** convalescent plasma

## Key facts

- **NCT ID:** NCT04565197
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565197, "Convalescent Plasma Therapy for COVID-19 Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04565197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*